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Abstract: I n t r o d u c t i o n: Infective endocarditis (IE) is a potentially life-threatening condition. 
According to current ESC (European Society of Cardiology) guidelines, the use of antibiotic prophylaxis 
should only be reserved for specifi c dental procedures with interruption of consistency of the oral mucosa 
such as extractions and should be reserved for patients with the highest risk of developing IE. Th e aim 
of this study was to assess the knowledge of need for IE prophylaxis in defi ned clinical settings among 
Polish dentists.
M a t e r i a l  a n d  M e t h o d s: A specially self-designed internet questionnaire was created concerning 
the topic of infective endocarditis prophylaxis in specifi c clinical scenarios for patients undergoing dental 
extractions during outpatient visits. Th e survey was made available to the dentists via internet and was 
active in March 2018.
R e s u l t s: Th ere were 352 Polish dentists who completed the survey. Antibiotic prophylaxis for IE during 
dental extractions was used in 93% of cases with prior IE, 89% with artifi cial heart valve, 69% with 
biological valve, 28% with pacemaker, 54% with coronary stent, 73% with cyanotic heart defect, 58% 
with diabetes mellitus, 20% aft er prior myocardial infarction and 54% with heart valve disease. Th ere 
was a signifi cant relationship between the time of working as a physician (>15 years) and more outdated 
or improper IE prophylaxis (p = 0.04).
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C o n c l u s i o n s: Th e management of patients for infective endocarditis prophylaxis undergoing dental 
extractions is suboptimal. Antibiotic therapy is overused in some clinical scenarios and on the other hand 
underutilized in those recommended by the current ESC guidelines.
Key words: infective endocarditis, prevention, dentists.
Introduction
Infective endocarditis (IE) is a potentially life-threatening condition caused by 
streptococci infection which may also be caused by residual bacteria of the human 
oral cavity [1, 2]. Appropriate prevention of IE reduces severe complications and 
mortality rates [3–6]. However, the balance between risks and benefi ts of antibiotic 
treatment should always be carefully evaluated in individual patients [7]. Experts 
emphasise dominant impact of remittent bacteriemia caused by daily hygienic 
procedures of oral cavity such as toothbrushing, rather than the infl uence of invasive 
medical procedures [8–13]. Th is and the lack of strong evidence showing robust 
benefi t from IE prophylaxis succeeded in recommendation that wise and preferably 
preservative administration of antibiotics should be performed [13–16].
According to current ESC (European Society of Cardiology) guidelines, the use 
of antibiotic prophylaxis should only be reserved for specifi c dental procedures with 
interruption of consistency of the oral mucosa such as extractions and should be 
reserved for patients with the highest risk of developing IE. Th ese patients include: 
those with previous IE, cyanotic CHD (congenital heart disease) and prosthetic valves 
or any other foreign material used for native valve repair or to correct CHD [17–20]. 
Growing number of patients with prosthetic valve replacement surgery every year 
including novel TAVI procedures certainly widens the population at risk of IE and 
need for prophylaxis [21].
Th e aim of this study was to assess the knowledge of need for IE prophylaxis in 
defi ned clinical settings among Polish dentists.
Material and Methods
A specially self-designed internet questionnaire was created concerning the topic of 
infective endocarditis prophylaxis in specifi c clinical scenarios for patients undergoing 
dental extractions during outpatient visits. It consisted of 12 questions. Th e initial 
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3 questions were related to general information: years of dental practice, board 
certifi cation and performing dental extractions. Board certifi cation was defi ned as 
having any formal specialist title in at least one of 7 fi elds (dental surgery, maxillofacial 
surgery, orthodontics, periodontology, prosthetics, children’s dentistry, dentistry with 
endodontics). Another 9 questions asked about IE prophylaxis in diff erent clinical 
settings (presence of prosthetic valve, prior IE, cyanotic CHD or corrected CHD up 
to 6 months from procedure, valvular disease, presence of biological valve, coronary 
stent, prior MI, diabetes mellitus, pacemaker). Questions wording and accuracy was 
consulted independently by both a specialist cardiologist and a specialist dentist. 
Th e survey was made available to the dentists via internet. Invitation was sent to 
potential participants in cooperation with and through the database of the members 
of the Polish Dental Association (Polskie Towarzystwo Stomatologiczne, PTS). Th e 
survey was active throughout March 2018. Th e study was voluntary and anonymous. 
Participants acknowledged consent for scientifi c data use, thus the study did not 
require Ethics Committee approval.
Statistical analysis
Standard descriptive statistics were used in this manuscript. Categorical variables 
were presented as counts and percentages. Th e chi-squared test was used to evaluate 
the correlation of qualitative data. A p value <0.05 was considered as statistically 
signifi cant. All analyses were performed with Statistica 12 commercial soft ware 
(StatSoft , Inc. Tulsa, OK, USA).
Results
Th ere were 352 Polish dentists who completed the survey and 310 among them 
perform dental extractions as part of their dental practice (88%). Majority (80%) of 
them had practiced dentistry for over 5 years and 44% of them was board certifi ed 
in any dental specialization. Th e prevalence of antibiotic prophylaxis for IE both 
in guideline-recommended clinical settings as well as some historical ones or 
contraindicated clinical scenarios are presented in Figure 1. Additional analysis of 
the percentage of IE prophylaxis in dental patients undergoing dental extractions in 
the clinical settings described above with relation to the number of years of medical 
practice as well as presence of board certifi cation is presented in Tables 1 and 2 
respectively.
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Fig. 1. IE prevention according to cardiovascular disease.














Prior IE 95% 94% 92% 0.701 0.903 0.665 0.605
Prosthetic valve 94% 94% 85% 0.043* 0.899 0.040* 0.029*
Cyanotic CHD 82% 80% 65% 0.007* 0.711 0.001* 0.022*
Biological valve 57% 66% 77% 0.008* 0.031* 0.001* 0.045*
Pacemaker 23% 27% 32% 0.393 0.445 0.333 0.292
Coronary stent 47% 56% 56% 0.423 0.356 0.301 0.899
Diebates mellitus 44% 64% 61% 0.031* 0.002* 0.041* 0.677
Valvular CHD 63% 51% 52% 0.277 0.196 0.255 0.850
Prior MI 19% 25% 17% 0.256 0.345 0.675 0.199
* p <0.05
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n = 174 p =
Prior IE 92% 94% 0.416
Prosthetic valve 88% 91% 0.349
Cyanotic CHD 70% 76% 0.236
Biological valve 70% 69% 0.866
Pacemaker 29% 28% 0.920
Coronary stent 53% 55% 0.696
Diebates mellitus 65% 52% 0.019*
Valvular CHD 56% 52% 0.529
Prior MI 19% 20% 0.827
* p <0.05
Discussion
Th is is best to our knowledge the fi rst nationawide and contemporary attempt 
to evaluate IE prophylaxis for dental extractions and the adherence to current 
ESC guidelines among Polish dentists. In our study, we have noticed that ca. 90% 
of dentists are providing antibiotic pretreatment in high risk IE patients (prior IE, 
prosthetic valve) while only 73% is adhering to guidelines in patients with cyanotic 
CHD. It is also worth mentioning that artifi cial biological valve is still considered as 
a strong indication for prophylaxis among our study group (69%). Our results are 
similar to the study by Spittle et al. [22], because their survey showed that 95% of 
dental practitioners used prophylaxis in patients with history of endocarditis but only 
76% in patients with prosthetic valve. On the other hand, a study by Tomczak et al. 
has revealed a very poor adherence to guidelines when it comes to prior IE with only 
75% prescribing prohylaxis and 70% with a prosthetic valve [23]. Over 50% of patients 
with such risk factors and comorbidities like DM, coronary stents and valvular CHD 
are still treated with antibiotics for dental extractions in Poland according to our 
study. Th e abovementioned results are probably based on the dentists experience and 
general knowledge but certainly not current recommendations. Th is is especially true 
for DM patients who are signifi cantly more oft en treated with antibiotics by dentists 
practicing 15 years and more. Th e newest guidelines are moderately recent (2015) and 
have changed the approach to IE prophylaxis which could also be the reason for our 
results.
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We have shown that there is a statistical signifi cance between years of clinical 
experience as a dental professional and underutilization of IE prophylaxis in high 
risk patients. More experienced dentists (over 15 years of practice) prescribe 
antibiotics significantly less frequently in cases of prosthetic valve and cyanotic 
CHD, which could be caused by outdated knowledge. It is interesting that dentists 
with minor experience (<5 years) provide better guideline-recommended adherence 
to IE prophylaxis. Interestingly, these practitioners seldom uses prophylaxis in other 
diseases such as DM. It seems that younger dentists who have had their fi nal exams 
and entrance exams for specialist training have better current knowledge than their 
older collegues who might not train or attend updateded seminars in this fi eld. Th e 
overuse of prophylaxis with antibiotics in patients aft er MI or with coronary stent is 
worriesome since there are over 100 000 such patients each year in Poland alone [21]. 
Th is unprecedented off -label use of antibiotics might cause individual complications 
as well as bacterial resistance. According to Cloitre et al. [24] only 34.5% from 12 000 
French responders had overall knowledge about current IE guidelines. Spanish data 
reveal that antibiotics are overutilized in IE prevention setting that does not require 
prophylaxis [25]. We have also shown that board certifi cation itself does not seem to 
infl uence better adherence to guidelines in terms of IE prophylaxis.
Guidelines have gone through major changes and are updated every several years. 
It seems that the knowledge among Polish dentists and their use of IE prophylaxis in 
clinical everyday practice is suboptimal and requires constant medical education so as 
to follow current evidence based medicine.
Limitations
Th e main limitation is a small study sample. We also did not ask specifi c questions 
concerning the details of the prophylaxis eg. names and doses of antibiotics and types 
of dental procedures that would require such, however, the main aim was to assess 
the adherence to current clinical indications for IE prophylaxis rather than enhance 
the questionnaire which could jeopardize the number of dentists who would fi ll it 
in. Th e internet survey certainly does not represent the entire dentist population in 
Poland (response rate ca. 10%).
Conclusions
Th e management of patients for infective endocarditis prophylaxis undergoing dental 
extractions is suboptimal. Antibiotic therapy is overused in some clinical scenarios 
and on the other hand underutilized in those recommended by the current ESC 
guidelines. Th is observation in especially true in dentists with over 15 years of dental 
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practice experience. More educational eff orts among dentists in Poland needs to be 
undertaken to change this pattern.
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